Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAP3K13 Antikörper (AA 801-900)

MAP3K13 Reaktivität: Human, Maus WB, ELISA, IF (cc), IF (p), IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN5557380
  • Target Alle MAP3K13 Antikörper anzeigen
    MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
    Bindungsspezifität
    • 14
    • 13
    • 7
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 801-900
    Reaktivität
    • 54
    • 29
    • 14
    • 1
    • 1
    • 1
    • 1
    Human, Maus
    Wirt
    • 51
    • 3
    Kaninchen
    Klonalität
    • 53
    • 1
    Polyklonal
    Konjugat
    • 19
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MAP3K13 Antikörper ist unkonjugiert
    Applikation
    • 42
    • 26
    • 18
    • 12
    • 12
    • 5
    • 3
    • 2
    • 2
    • 2
    Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Kreuzreaktivität
    Human, Maus
    Homologie
    Cow
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human MAP3K13
    Isotyp
    IgG
    Top Product
    Discover our top product MAP3K13 Primärantikörper
  • Applikationshinweise
    WB 1:300-5000
    ELISA 1:500-1000
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    ICC 1:100-500
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Haltbarkeit
    12 months
  • Target
    MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
    Andere Bezeichnung
    MAP3K13 (MAP3K13 Produkte)
    Synonyme
    LZK antikoerper, MEKK13 antikoerper, MLK antikoerper, C130026N12Rik antikoerper, lzk antikoerper, map3k13 antikoerper, map3k13a antikoerper, mekk13 antikoerper, map3k13-a antikoerper, map3k13-b antikoerper, map3k13b antikoerper, mitogen-activated protein kinase kinase kinase 13 antikoerper, mitogen-activated protein kinase kinase kinase 13 L homeolog antikoerper, mitogen-activated protein kinase kinase kinase 13 S homeolog antikoerper, MAP3K13 antikoerper, Map3k13 antikoerper, map3k13.L antikoerper, map3k13 antikoerper, map3k13.S antikoerper
    Hintergrund

    Synonyms: Mitogen-activated protein kinase kinase kinase 13, MAP3K13, Leucine zipper-bearing kinase, Mixed lineage kinase, MLK, LZK

    Background: Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.

    Gen-ID
    9175
    UniProt
    O43283
    Pathways
    Signaling Events mediated by VEGFR1 and VEGFR2
Sie sind hier:
Kundenservice